FGFR-IN-4
FGFR-IN-4 is a potent inhibitor of FGFR. Fibroblast growth factor receptor (FGFR) is a tyrosine kinase receptor that binds to fibroblast growth factor ligands. FGFR-IN-4 has the potential for the research of cancer diseases (extracted from patent WO2022033532A1, compound 20) [1]. FGFR-IN-4 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Product Specifications
CAS Number
2761211-49-6
UNSPSC
12352005
Target
FGFR
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/fgfr-in-4.html
Solubility
10 mM in DMSO
Smiles
C=CC(N1CC[C@@H](C1)N2N=C(C3=C2N=CN=C3N)C#CC4=CC5=C(OC(C6CC6)=N5)C=C4)=O
Molecular Formula
C24H21N7O2
Molecular Weight
439.47
References & Citations
[1]Haibin Deng, et al. Fgfr and mutation inhibitor thereof, and preparation method therefor and use thereof. Patent WO2022033532A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
PSG11 (Pregnancy-specific beta-1-glycoprotein 11, PS-beta-G-11, PSBG-11, Pregnancy-specific Glycoprotein 11, Pregnancy-specific beta-1-glycoprotein 13, PS-beta-G-13, PSBG-13, Pregnancy-specific Glycoprotein 13, PSG13, PSG14, MGC22484)
PSG11 (Pregnancy-specific beta-1-glycoprotein 11, PS-beta-G-11, PSBG-11, Pregnancy-specific Glycoprotein 11, Pregnancy-specific beta-1-glycoprotein 13, PS-beta-G-13, PSBG-13, Pregnancy-specific Glycoprotein 13, PSG13, PSG14, MGC22484)
RPL21P93 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)
DVL1L1 (Putative Segment Polarity Protein Dishevelled Homolog DVL1P1, DSH Homolog 1-like, Segment Polarity Protein Dishevelled Homolog DVL-1-like, Dishevelled-1-like, DVL1P1, DVL, DVL1, DVL1L1) (MaxLight 750) discontinued
IRS1, phosphorylated (S312) (Insulin Receptor Substrate 1, HIRS-1) discontinued